Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy

Pharmaceutical Research

Volumn 21, Issue 3, 2004, Pages 400-405

  Wissing, Sylvia A ^a   Müller, Rainer H ^a   Manthei, Lars ^b   Mayer, Christian ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Nuclear magnetic resonance; Solid lipid nanoparticles; Spin diffusion; Spin lattice relaxation in the rotating frame (T1p)

Indexed keywords

NANOPARTICLE; SOLID LIPID NANOPARTICLE; UBIDECARENONE; DRUG CARRIER; LIPID; PROTON;

ACCELERATION; ARTICLE; DIFFUSION; DRUG FORMULATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; ROTATION; SOLID STATE; STRUCTURE ANALYSIS; CHEMISTRY;

DRUG CARRIERS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; PROTONS;

EID: 12144288430     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000019291.36636.c1     Document Type: Article

References (38)

1. R. H. Müller and J. S. Lucks. Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN). European Patent EP 0605497 (1996).
2. R. H. Müller, A. Dingler, H. Weyhers, A. zur Mühlen, and W. Mehnert. Solid lipid nanoparticles (SLN) - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. III. Langzeitstabilität, Gefrier-und Sprühtrocknung. Pharm. Ind. 59:614-619 (1997).
3. H. Heiati, R. Tawashi, and N. C. Phillips. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencaps. 15:173-184 (1998).
4. C. Freitas and R. H. Müller. Spray drying of solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 46:145-151 (1998).
5. E. Zimmermann, R. H. Müller, and K. Mäder. Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm. 19:211-213 (2000).
6. A. Radomska, R. Dobrucki, and R. H. Müller. Chemical stability of the lipid matrices of solid lipid nanoparticles (SLN) - development of the analytical method and determination of long-term stability. Pharmazie 54: 903-909 (1999).
7. H. Heiati, R. Tawashi, R. R. Shivers, and N. C. Phillips. Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate. Int. J. Pharm. 146:123-131 (1997).
8. W. Mehnert, A. zur Mühlen, A. Dingler, H. Weyhers, and R. H. Müller. Solid lipid nanoparticles (SLN) - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. II. Wirkstoff-Irkorporation, Freisetzung und Sterilisierbarkeit. Pharm. Ind. 59: 511-514 (1997).
9. S. A. Wissing and R. H. Müller. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control Rel. 81:225-233 (2002).
10. A. zur Mühlen, C. Schwarz, and W. Mehnert. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 45:149-155 (1998).
11. V. Jenning, M. Schäfer-Korting, and S. Gohla. Vitamin A loaded solid lipid nanoparticles for topical application: drug release properties. J. Controlled Release 66:115-126 (2000).
12. D. B. Chen, T. Z. Yang, W. L. Lu, and Q. Zhang. In vitro and in vivo study of two types of long-circulating solid lipid nanopartioles containing paclitaxel. Chem. Pharm. Bull. 49:1444-1447 (2001).
13. S. A. Wissing and R. H. Müller. The influence of solid lipid nanoparticles (SLN) on skin hydration and viscoelasticity - in vivo study. Eur. J. Pharm. Biopharm. 561:67-72 (2003).
14. A. Fundaro, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara, and M. R. Gasco. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharm. Res. 42:337-343 (2000).
15. S. Yang, J. Zhu, Y. Lu, B. Liang, and C. Yang. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res. 16:751-757 (1999).
16. R. H. Müller, M. Radtke, and S. A. Wissing. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Del. Rev. 54:S131-S155 (2002).
17. S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang, and C. Z. Yang. Body distribution in vice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Rel. 59:299-307 (1999).
18. R. H. Müller, W. Mehnert, J. S. Lucks, C. Schwarz, A. zur Mühlen, H. Weyhers, C. Freitas, and D. Rühl. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:62-69 (1995).
19. R. H. Müller, K. Mäder, and S. Gohla. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50:161-178 (2000).
20. W. Mehnert and K. Mäder. Solid lipid nanoparticles - production characterization and applications. Adv. Drug Del. Rev. 47:165-196 (2001).
21. V. Jenning and S. H. Gohla. Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int. J. Pharm. 196:219-222 (2000).
22. G. Lukowki, J. Kasbohm, P. Pflegel, A. Illing, and H. Wulff. Crystallographic investigation of cetyl palmitate solid lipid nanoparticles. Int. J. Pharm. 196:201-205 (2000).
23. 1H-NMR study. Int. J. Pharm. 205:15-21 (2000).
24. K. Westesen and T. Wehler. Physicochemical characterization of a model intravenous oil-in-water emulsion. J. Pharm. Sci. 81:777-786 (1992).
25. K. Westesen and T. Wehler. Investigation of the particle size distribution of a model intravenous emulsion. J. Pharm. Sci. 82: 1237-1244 (1993).
26. K. Westesen, A. Gerke, and M. H. J. Koch. Characterization of native and drug-loaded human low density lipoproteins. J. Pharm. Sci. 84:139-147 (1995).
27. K. Westesen, H. Bunjes, and M. H. J. Koch. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Rel. 48:223-226 (1997).
28. 1H-NMR as a method to characterize colloidal carrier systems. Proc. Intl. Symp. Control. Rel. Bioact. Mater. 26:595-596 (1999).
29. S. Liedtke, E. Zimmermann, R. H. Müller, and K. Mäder. Physical characterisation of solid lipid nanoparticles (SLN™). Proc. Intl. Symp. Control. Rel. Bioact. Mater. 26:599-600 (1999).
30. D. Hoffmann and C. Mayer. Cross polarization induced by temporary adsorption: NMR investigations on nanocapsule dispersions. J. Chem. Phys. 112:4242-4250 (2000).
31. C. Mayer. Nuclear magnetic resonance on dispersed nanoparticles. Prog. Nucl. Reson. Spectrosc. 40:307-365 (2002).
32. C. Mayer and G. Lukowski. Solid state NMR investigations on nanosized carrier systems. Pharm. Res. 17:486-489 (2000).
33. S. Guinebretiere, S. Briancon, J. Lieto, C. Mayer, and H. Fessi. Study on the emulsion-diffusion of solvent: preparation and characterization of nanocapsules. Drug Dev. Res. 57:18-33 (2002).
34. C. Mayer, D. Hoffmann, and M. Wohlgemuth. Structural analysis of nanocapsules by nuclear magnetic resonance. Int. J. Pharm. 242:37-46 (2002).
35. W. S. Veeman and W. E. J. R. Maas. Solid state NMR techniques for the study of polymer-polymer miscibility. In P. Diehl, E. Fluck, H. Günther, R. Kosfeld, and J. Seelig (eds.), NMR: Basic Principles and Progress, Springer-Verlag, Berlin, 1994, pp. 131-162.
36. A. Dingler. Feste Lipid-Nanopartikel als kolloidale Wirkstoffträ gersysteme zur dermalen Applikation, Ph.D. Thesis, FU Berlin (1998).
37. H. Bunjes, M. H. J. Koch, and K. Westesen. Effect of particles size on colloidal solid triglycerides. Langmuir 16:5234-5241 (2000).
38. K. Westesen and H. Bunjes. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int. J. Pharm. 115:129-131 (1995).